Sign in
☰
People MPsHouse of LordsGovernmentOppositionPartiesCommittees Votes Commons votesLords votesVotes by issueTopicsStats & rankingsParliament in numbers Legislation BillsEarly day motionsPetitions Elections Election resultsConstituenciesWho is my MP? Scotland OverviewMSPsScottish GovernmentVotesBillsMotionsCommitteesConstituencies & regionsElections Search Sign in

Motion · S6M-19290 · 8 Oct 2025

Research Funding for DIOKA Therapeutics

Lodged by Kevin Stewart Standard Motion 21 supporters

The motion

That the Parliament welcomes the news that DIOKA Therapeutics, which is a University of Aberdeen pre-spinout company, has been awarded £125,000 by the Scottish Funding Council to develop a new way of treating high blood pressure; notes that high blood pressure, which is also called hypertension, is the leading cause of early death worldwide, and that current treatments are not always effective; understands that this new treatment is based on research by a team led by Dr Guy Bewick, who is the Senior Lecturer in Neurosciences at the University and the Chief Scientific Officer at DIOKA; notes that the team has identified sensors in the body that monitor blood pressure, and seeks to use these to take advantage of the body’s natural blood pressure regulatory circuit; believes that, if the development of this new type of drug is successful, it could revolutionise treatment for hypertension, and wishes the team at DIOKA all the best in taking this work to the next stage.

Supporters (21)

Source: the Scottish Parliament motions and amendments record.